The Scientist

» cancer, cell & molecular biology and culture

Most Recent

image: Treating Cancer with CRISPR?

Treating Cancer with CRISPR?

By | June 17, 2016

A federal panel will review the first proposal for the use of the technology to edit human genes for medical purposes.

0 Comments

image: Creating a DNA Record with CRISPR

Creating a DNA Record with CRISPR

By | June 9, 2016

Researchers repurpose a bacterial immune system to be a molecular recording device.

0 Comments

image: TS Picks: June 6, 2016

TS Picks: June 6, 2016

By | June 6, 2016

American Society of Clinical Oncology meeting edition 

0 Comments

image: Book Excerpt from <em>Wondrous Truths</em>

Book Excerpt from Wondrous Truths

By | June 1, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

image: Generating Cardiac Precursor Cells

Generating Cardiac Precursor Cells

By | June 1, 2016

Researchers derive cardiac precursors to form cardiac muscle, endothelial, and smooth muscle cells in mice.

0 Comments

image: Hot Off the Presses

Hot Off the Presses

By | June 1, 2016

Beyond Biocentrism, The Sting of the Wild, The Birth of Anthropocene, and Ordinarily Well

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | June 1, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

image: Screening  with CRISPR

Screening with CRISPR

By | June 1, 2016

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Start Making Sense

Start Making Sense

By | June 1, 2016

Scientific progress is only achieved when humans' innate sense of understanding is validated by objective reality.

6 Comments

image: The Fatty Acid–Ketone Switch

The Fatty Acid–Ketone Switch

By | June 1, 2016

In failing hearts, cardiomyocytes change their fuel preference.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech